tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Dr. Reddy’s, Alvotech announce FDA acceptance of AVT03 BLA

Dr. Reddy’s (RDY) and Alvotech (ALVO) announced that the FDA has accepted a 351(k) biologic license application submission for AVT03, developed by Alvotech, a proposed biosimilar of Prolia and Xgeva.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1